Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma

Cell Death and Disease

Volumn 5, Issue 12, 2014, Pages

  Tudor, S ^a,b   Giza, D E ^a,b   Lin, H Y ^c   Fabris, L ^a   Yoshiaki, K ^a   D'Abundo, L ^a   Toale, K M ^c   Shimizu, M ^a   Ferracin, M ^d   Challagundla, K B ^e   Angelica Cortez, M ^a   Fuentes Mattei, E ^a   Tulbure, D ^b   Gonzalez, C ^c   Henderson, J ^c   Row, M ^c   Rice, T W ^c   Ivan, C ^c   Negrini, M ^d   Fabbri, M ^e   Morris, J S ^c   Yeung, S C J ^c   Vasilescu, C ^b   Calin, G A ^a,c   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b FUNDENI CLINICAL INSTITUTE   (Romania)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; MICRORNA; MICRORNA 10B; MICRORNA 12; MICRORNA 146A; MICRORNA 150; MICRORNA 155; MICRORNA 16; MICRORNA 182; MICRORNA 223; MICRORNA 23A; MICRORNA 26A; MICRORNA 29; MICRORNA 342; MICRORNA 486; MICRORNA 93; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG; VIRUS RNA; IL6 PROTEIN, HUMAN; INTERLEUKIN 8; TLR8 PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRIDAE; HUMAN; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SURGICAL INJURY; AGED; APACHE; BLOOD; CASE CONTROL STUDY; ETHNOLOGY; FEEDBACK SYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN HERPESVIRUS 8; INJURY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; MORTALITY; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

AFRICAN AMERICANS; AGED; APACHE; CASE-CONTROL STUDIES; FEEDBACK, PHYSIOLOGICAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HERPESVIRUS 8, HUMAN; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; MIDDLE AGED; SARCOMA, KAPOSI; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TOLL-LIKE RECEPTOR 8; WOUNDS AND INJURIES;

EID: 84927931437     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.515     Document Type: Article

References (29)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.
2. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34: 344-353.
3. Moore LJ, McKinley BA, Turner KL, Todd SR, Sucher JF, Valdivia A et al. The epidemiology of sepsis in general surgery patients. J Trauma 2011; 70: 672-680.
4. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-575.
5. Nahid MA, Satoh M, Chan EK. MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 2011; 8: 388-403.
6. Larange A, Antonios D, Pallardy M, Kerdine-Romer S. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation. J Leukoc Biol 2009; 85: 673-683.
7. Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 2012; 109: E2110-E2116.
8. Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 2012; 15: 827-835.
9. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596.
10. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis ofsepsis. Annu Rev Pathol 2011; 6: 19-48.
11. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010; 14: R15-12.
12. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
13. Wang H, Zhang P, Chen W, Feng D, Jia Y, Xie. Serum microRNA signatures identified by Solexa sequencing predict sepsis patients mortality: a prospective observational study. PLoS One 2012; 7: e38885.
14. Plaisance-Bonstaff K, Renne R. Viral miRNAs. Methods Mol Biol 2011; 721: 43-66.
15. Uldrick TS, Wang V, O'Mahony D, Aleman K, Wyvill KM, Marshall V et al. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis 2010; 51: 350-358.
16. Guilluy C, Zhang Z, Bhende PM, Sharek L, Wang L, Burridge K et al. Latent KSHV infection increases the vascular permeability of human endothelial cells. Blood 2011; 118: 5344-5354.
17. Qin Z, Kearney P, Plaisance K, Parsons CH. Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol 2010; 87: 25-34.
18. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M et al. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 2009; 4: e7405.
19. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146-159.
20. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response.Proc Natl Acad Sci USA 2007; 104: 1604-1609.
21. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011; 306: 2594-2605.
22. Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci USA 2005; 102: 5570-5575.
23. Gregory SM, Damania B. KSHV and the toll of innate immune activation. Cell Cycle 2009; 8: 3246-3247.
24. Wang HE, Devereaux RS, Yealy DM, Safford MM, Howard G. National variation in United States sepsis mortality: a descriptive study. Int J Health Geogr 2010; 9: 9.
25. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012; 12: 919-924.
26. Pelletier SJ, Isaacs RB, Raymond DP, Crabtree TD, Spencer CE, Gleason TG et al. Ethnic disparities in outcome from posttransplant infections. Shock 2004; 22: 197-203.
27. Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest 2006; 129: 1432-1440.
28. Vogel TR, Dombrovskiy VY, Lowry SF. Trends in postoperative sepsis: are we improving outcomes?. Surg Infect (Larchmt ) 2009; 10: 71-78.
29. Claydon JE, Mitton C, Sankaran K, Lee SK. Ethnic differences in risk factors for neonatal mortality and morbidity in the neonatal intensive care unit. J Perinatol 2007; 27: 448-452.